[Effect of tardokrein in vascular diseases of the nervous system].
D000208:Acute Disease; D000368:Aged; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D004361:Drug Tolerance; D004562:Electrocardiography; D004569:Electroencephalography; D005069:Evaluation Studies as Topic; D005121:Extremities / Q000098:blood supply; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy; D007610:Kallikreins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D002784:Cholesterol; D007610:Kallikreins
Ocena cziałania tardókreiny w chorobach naczyniowych układu nerwowego.